Ratings by Wells Fargo (Vik Chopra)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | Solventum | SOLV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/27/2026 | Integra LifeSciences | IART | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/27/2026 | DENTSPLY SIRONA | XRAY | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/26/2026 | Globus Medical | GMED | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/25/2026 | Henry Schein | HSIC | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/18/2026 | Masimo Corp. | MASI | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/6/2026 | Envista Holdings Corp. | NVST | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/5/2026 | Align Technology | ALGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Globus Medical | GMED | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Alphatec Holdings | ATEC | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Solventum | SOLV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 11/5/2025 | Masimo Corp. | MASI | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/5/2025 | Henry Schein | HSIC | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 10/31/2025 | Alphatec Holdings | ATEC | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/30/2025 | Align Technology | ALGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/30/2025 | Align Technology | ALGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/16/2025 | Alphatec Holdings | ATEC | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Globus Medical | GMED | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Enovis Corp | ENOV | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Solventum | SOLV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/8/2025 | DENTSPLY SIRONA | XRAY | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/6/2025 | Henry Schein | HSIC | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 7/31/2025 | Align Technology | ALGN | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/9/2025 | Globus Medical | GMED | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/9/2025 | Enovis Corp | ENOV | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/9/2025 | DENTSPLY SIRONA | XRAY | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 5/7/2025 | Masimo Corp. | MASI | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/6/2025 | Integra LifeSciences | IART | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 5/6/2025 | Henry Schein | HSIC | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/28/2025 | Solventum | SOLV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/26/2025 | Masimo Corp. | MASI | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/21/2025 | Globus Medical | GMED | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/14/2025 | Henry Schein | HSIC | New Coverage | Equal Weight (N/A) |
77.62 (77.60) |
-0.03% | Details | |
| 2/14/2025 | Align Technology | ALGN | New Coverage | Overweight (N/A) |
204.89 (174.00) |
-15.08% | Details | |
| 2/14/2025 | DENTSPLY SIRONA | XRAY | New Coverage | Equal Weight (N/A) |
18.77 (12.74) |
-32.13% | Details | |
| 11/8/2024 | Solventum | SOLV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/7/2024 | Enovis Corp | ENOV | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2024 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2024 | Masimo Corp. | MASI | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2024 | Alphatec Holdings | ATEC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2024 | Alphatec Holdings | ATEC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2024 | Masimo Corp. | MASI | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2024 | Solventum | SOLV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/7/2024 | Globus Medical | GMED | Upgrade | Overweight (Equal Weight) |
69.05 (87.10) |
26.14% | Details | |
| 5/9/2024 | Globus Medical | GMED | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/7/2024 | Integra LifeSciences | IART | Downgrade | Equal Weight (Overweight) |
28.89 (9.73) |
-66.32% | Details | |
| 4/8/2024 | Solventum | SOLV | New Coverage | Equal Weight (N/A) |
67.00 (69.41) |
3.6% | Details | |
| 3/25/2024 | Masimo Corp. | MASI | Upgrade | Overweight (Equal Weight) |
134.93 (175.42) |
30.01% | Details | |
| 2/29/2024 | Integra LifeSciences | IART | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2024 | Enovis Corp | ENOV | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2023 | Integra LifeSciences | IART | Upgrade | Overweight (Equal Weight) |
40.38 (9.73) |
-75.9% | Details | |
| 11/8/2023 | Enovis Corp | ENOV | Maintain | Overweight (N/A) |
|
Details | ||
| 9/15/2023 | Globus Medical | GMED | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/4/2023 | Globus Medical | GMED | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/12/2023 | Enovis Corp | ENOV | Upgrade | Overweight (Equal Weight) |
55.79 (24.51) |
-56.07% | Details | |
| 2/22/2023 | Globus Medical | GMED | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/10/2023 | Globus Medical | GMED | Downgrade | Equal Weight (Overweight) |
62.97 (87.10) |
38.32% | Details | |
| 2/10/2023 | NuVasive | NUVA | Downgrade | Equal Weight (Overweight) |
47.13 (39.75) |
-15.66% | Details | |
| 12/12/2022 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2022 | Enovis Corp | ENOV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/21/2022 | Enovis Corp | ENOV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 6/16/2022 | Enovis Corp | ENOV | New Coverage | Equal Weight (N/A) |
61.20 (24.51) |
-59.95% | Details | |
| 5/11/2022 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2022 | NuVasive | NUVA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/28/2022 | NuVasive | NUVA | New Coverage | Overweight (N/A) |
51.94 (39.75) |
-23.47% | Details | |
| 3/28/2022 | Globus Medical | GMED | New Coverage | Overweight (N/A) |
70.99 (87.10) |
22.69% | Details |
